National Assembly for Wales

WAQ75601 (e) Tabled on 10/01/2018

What plans does the Cabinet Secretary have to extend the availability of Savitex to multiple sclerosis sufferers in Wales?

Answered by First Minister Answered on 18/01/2018

Sativex is routinely available as an option to treat multiple sclerosis sufferers in Wales who meet the clinical criteria specified by the All-Wales Medicines Strategy Group and who are likely to benefit from it. This is for individual clinicians to determine.

Explore the National Assembly for Wales